Triptorelin

Category
peptide
Half-Life (t½)
IM: 4h
Formula
C64H82N18O13
Molecular Weight
1311.4 g/mol
PubChem CID
25074470
Aliases
Trelstar, Decapeptyl, Pamorelin

Pharmacological Mechanism

Decapeptide GnRH analog — D-Trp⁶ substitution stabilises against pituitary peptidases. Like leuprolide, an initial LH/FSH/testosterone flare (clinically relevant in prostate cancer — pre-treat with anti-androgen) transitions to chronic pituitary GnRH-R desensitisation and castrate gonadal steroids within ~3–4 weeks. Depot microsphere / embonate salt formulations provide 1, 3, or 6 month durations of action.

Half-Life & Elimination Curve (IM: 4h)

100%50%25%12.5%0%0h0×t½4h1×t½8h2×t½12h3×t½16h4×t½20h5×t½0×t½ (0h): 100% remaining (~19.3 µg/L)1×t½ (4h): 50% remaining (~9.64 µg/L)2×t½ (8h): 25% remaining (~4.82 µg/L)3×t½ (12h): 12.5% remaining (~2.41 µg/L)4×t½ (16h): 6.3% remaining (~1.2 µg/L)5×t½ (20h): 3.1% remaining (~0.602 µg/L)
Plasma (IM)t½ Decay (4h)
  • 0×t½0h100% (19.3 µg/L)
  • 1×t½4h50% (9.64 µg/L)
  • 2×t½8h25% (4.82 µg/L)
  • 3×t½12h12.5% (2.41 µg/L)
  • 4×t½16h6.3% (1.2 µg/L)
  • 5×t½20h3.1% (0.602 µg/L)
Elimination t½4h (IM)
Rate Constant (ke)0.173 h⁻¹
Time to Peak (Tmax)12.2h
Est. Peak (Cmax)19.3 µg/L
Clearance (CL)3.64 L/h
97% Washout (5×t½)20h

Dosing Guidelines

Pharmacokinetic Parameters

Pathways It Modulates

Target Organ Systems

Chemical Structure & Identifiers

References